Early circulating tumour DNA (ctDNA) dynamics for predicting and monitoring response to immunotherapy (IO) vs chemotherapy (CT) in patients with 1L metastatic (m) NSCLC: Analyses from the phase III MYSTIC trial Meeting Abstract


Authors: Peters, S.; Rizvi, N. A.; Kuziora, M.; Lai, Z.; Shrestha, Y.; Dey, A.; Barrett, J. C.; Scheuring, U.; Poole, L.; Abbosh, C.; Raja, R.; Hellmann, M. D.
Abstract Title: Early circulating tumour DNA (ctDNA) dynamics for predicting and monitoring response to immunotherapy (IO) vs chemotherapy (CT) in patients with 1L metastatic (m) NSCLC: Analyses from the phase III MYSTIC trial
Meeting Title: ESMO Congress 2021
Journal Title: Annals of Oncology
Volume: 32
Issue: Suppl. 5
Meeting Dates: 2021 Sep 16-21
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2021-09-01
Start Page: S989
End Page: S990
Language: English
ACCESSION: WOS:000700527702279
DOI: 10.1016/j.annonc.2021.08.1866
PROVIDER: wos
Notes: Meeting Abstract: 1264P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Matthew David Hellmann
    412 Hellmann